Literature DB >> 19343319

Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line.

S A Sarkar1, B Kutlu, K Velmurugan, S Kizaka-Kondoh, C E Lee, R Wong, A Valentine, H W Davidson, J C Hutton, S Pugazhenthi.   

Abstract

AIMS/HYPOTHESIS: The destruction of pancreatic beta cells leading to type 1 diabetes in humans is thought to occur mainly through apoptosis and necrosis induced by activated macrophages and T cells, and in which secreted cytokines play a significant role. The transcription factor nuclear factor kappa-B (NF-kappaB) plays an important role in mediating the apoptotic action of cytokines in beta cells. We therefore sought to determine the changes in expression of genes modulated by NF-kappaB in human islets exposed to a combination of IL1beta, TNF-alpha and IFN-gamma.
METHODS: Microarray and gene set enrichment analysis were performed to investigate the global response of gene expression and pathways modulated in cultured human islets exposed to cytokines. Validation of a panel of NF-kappaB-regulated genes was performed by quantitative RT-PCR. The mechanism of induction of BIRC3 by cytokines was examined by transient transfection of BIRC3 promoter constructs linked to a luciferase gene in MIN6 cells, a mouse beta cell line.
RESULTS: Enrichment of several metabolic and signalling pathways was observed in cytokine-treated human islets. In addition to the upregulation of known pro-apoptotic genes, a number of anti-apoptotic genes including BIRC3, BCL2A1, TNFAIP3, CFLAR and TRAF1 were induced by cytokines through NF-kappaB. Significant synergy between the cytokines was observed in NF-kappaB-mediated induction of the promoter of BIRC3 in MIN6 cells. CONCLUSIONS/
INTERPRETATION: These findings suggest that, via NF-kappaB activation, cytokines induce a concurrent anti-apoptotic pathway that may be critical for preserving islet integrity and viability during the progression of insulitis in type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343319     DOI: 10.1007/s00125-009-1331-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  49 in total

1.  c-IAP2 is induced by ionizing radiation through NF-kappaB binding sites.

Authors:  T Ueda; N Akiyama; H Sai; N Oya; M Noda; M Hiraoka; S Kizaka-Kondoh
Journal:  FEBS Lett       Date:  2001-02-23       Impact factor: 4.124

2.  Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets.

Authors:  P Ylipaasto; B Kutlu; S Rasilainen; J Rasschaert; K Salmela; H Teerijoki; O Korsgren; R Lahesmaa; T Hovi; D L Eizirik; T Otonkoski; M Roivainen
Journal:  Diabetologia       Date:  2005-07-01       Impact factor: 10.122

Review 3.  IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.

Authors:  Jun-Li Luo; Hideaki Kamata; Michael Karin
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.

Authors:  A K Cardozo; P Proost; C Gysemans; M-C Chen; C Mathieu; D L Eizirik
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

5.  Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells.

Authors:  C A Delaney; D Pavlovic; A Hoorens; D G Pipeleers; D L Eizirik
Journal:  Endocrinology       Date:  1997-06       Impact factor: 4.736

6.  Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis.

Authors:  H Heimberg; Y Heremans; C Jobin; R Leemans; A K Cardozo; M Darville; D L Eizirik
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

7.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

8.  Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death.

Authors:  C Bonny; A Oberson; S Negri; C Sauser; D F Schorderet
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

9.  NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice.

Authors:  Sunshin Kim; Isabelle Millet; Hun Sik Kim; Ja Young Kim; Myoung Sook Han; Moon-Kyu Lee; Kwang-Won Kim; Robert S Sherwin; Michael Karin; Myung-Shik Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

Review 10.  Cytokine receptor signalling.

Authors:  J N Ihle
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

View more
  40 in total

Review 1.  Targeting inflammation in diabetes: Newer therapeutic options.

Authors:  Neeraj Kumar Agrawal; Saket Kant
Journal:  World J Diabetes       Date:  2014-10-15

2.  METTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the NF-κB signaling pathway.

Authors:  Jian Huang; Yi-Hsiang Hsu; Maxrco Brotto; David Karasik; Chenglin Mo; Eduardo Abreu; Douglas P Kiel; Lynda F Bonewald
Journal:  J Bone Miner Res       Date:  2014-07       Impact factor: 6.741

3.  Tumor necrosis factor α-induced protein-3 protects zinc transporter 8 against proinflammatory cytokine-induced downregulation.

Authors:  Liqing Cheng; Dongmei Zhang; Bing Chen
Journal:  Exp Ther Med       Date:  2016-06-15       Impact factor: 2.447

4.  cJUN N-terminal kinase (JNK) activation mediates islet amyloid-induced beta cell apoptosis in cultured human islet amyloid polypeptide transgenic mouse islets.

Authors:  S L Subramanian; R L Hull; S Zraika; K Aston-Mourney; J Udayasankar; S E Kahn
Journal:  Diabetologia       Date:  2011-10-26       Impact factor: 10.122

5.  Baculoviral inhibitors of apoptosis repeat containing (BIRC) proteins fine-tune TNF-induced nuclear factor κB and c-Jun N-terminal kinase signalling in mouse pancreatic beta cells.

Authors:  B M Tan; N W Zammit; A O Yam; R Slattery; S N Walters; E Malle; S T Grey
Journal:  Diabetologia       Date:  2012-12-20       Impact factor: 10.122

6.  The C-terminal domain of A1/Bfl-1 regulates its anti-inflammatory function in human endothelial cells.

Authors:  Renata P Guedes; Eduardo Rocha; Jerome Mahiou; Herwig P Moll; Maria B Arvelo; Janis M Taube; Clayton R Peterson; Elzbieta Kaczmarek; Christopher R Longo; Cleide G da Silva; Christiane Ferran
Journal:  Biochim Biophys Acta       Date:  2013-03-13

7.  Gene expression profiles of Beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes.

Authors:  Lorella Marselli; Jeffrey Thorne; Sonika Dahiya; Dennis C Sgroi; Arun Sharma; Susan Bonner-Weir; Piero Marchetti; Gordon C Weir
Journal:  PLoS One       Date:  2010-07-13       Impact factor: 3.240

Review 8.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

9.  Dramatic co-activation of WWOX/WOX1 with CREB and NF-kappaB in delayed loss of small dorsal root ganglion neurons upon sciatic nerve transection in rats.

Authors:  Meng-Yen Li; Feng-Jie Lai; Li-Jin Hsu; Chen-Peng Lo; Ching-Li Cheng; Sing-Ru Lin; Ming-Hui Lee; Jean-Yun Chang; Dudekula Subhan; Ming-Shu Tsai; Chun-I Sze; Subbiah Pugazhenthi; Nan-Shan Chang; Shur-Tzu Chen
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

10.  Cytokine-induced dicing and splicing in the beta-cell and the immune response in type 1 diabetes.

Authors:  John C Hutton; Howard W Davidson
Journal:  Diabetes       Date:  2010-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.